Company Profiles

driven by the PitchBook Platform

Neograft Technologies

Description

Developer of a cardiac device designed to improve vein performance in coronary artery bypass. The company's cardiac device creates a support layer around the vein using a novel process called electrospinning allowing nutrients and new cells to migrate into and through the support layer without deforming its natural shape.

2009

Founded

PRIVATE

Status

11-50

Employees

Series C

Latest Deal Type

$5M

Latest Deal Amount

$37.3M

Total Amount Raised

Description

Developer of a cardiac device designed to improve vein performance in coronary artery bypass. The company's cardiac device creates a support layer around the vein using a novel process called electrospinning allowing nutrients and new cells to migrate into and through the support layer without deforming its natural shape.

Website:

www.neograftinc.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Surgical Devices

Primary Office

470 Constitution Drive Taunton, MA 02780United States
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Neograft Technologies's full profile, request a free trial.

    Neograft Technologies Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Neograft Technologies Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Neograft Technologies Investors (1)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    MAG VenturesPE/BuyoutMinority000 0000000 0000
    MAG Ventures PE/Buyout

    Neograft Technologies Executive Team (6)

    NameTitleBoard
    Seat
    Contact
    Info
    Jon McGrathChief Executive Officer, President & Board Member
    Mohammed El-Kurdi Ph.DCo-Founder & Director, Research
    David VorpCo-Founder & Advisor
    William WagnerCo-Founder & Advisor
    Steve LinharesVice President of Quality, Clinical & Regulatory
    Jon McGrath Chief Executive Officer, President & Board Member
    Mohammed El-Kurdi Ph.D Co-Founder & Director, Research
    David Vorp Co-Founder & Advisor
    William Wagner Co-Founder & Advisor
    Steve Linhares Vice President of Quality, Clinical & Regulatory

    Neograft Technologies Board Members (7)

    NameRepresentingRoleSinceContact
    Info
    Brad Petersen MDSelfBoard Member000 0000
    Christopher PetersenSelfChairman000 0000
    John PetersenSelfBoard Member000 0000
    Jon McGrathNeograft TechnologiesChief Executive Officer, President & Board Member000 0000
    Michael TovianSelfBoard Member000 0000
    Brad Petersen MD Board Member Self
    Christopher Petersen Chairman Self
    John Petersen Board Member Self
    Jon McGrath Chief Executive Officer, President & Board Member Neograft Technologies
    Michael Tovian Board Member Self
    Request full access to PitchBook